Clinical Trial Detail

NCT ID NCT02039726
Title (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Daiichi Sankyo Inc.
Indications

acute myeloid leukemia

Therapies

Cytarabine + Fludarabine

Cytarabine + Etoposide + Mitoxantrone

Quizartinib

Filgrastim + Idarubicin

Age Groups: senior adult

Additional content available in CKB BOOST